Axion, a pioneering AI platform transforming product quality in manufacturing, has raised $37 million in Series B funding to expand its human-in-the-loop quality intelligence platform. The round was led by Salesforce Ventures with participation from Bessemer Venture Partners, Schneider Electric Ventures, and existing investors, highlighting strong market confidence in Axion’s mission to modernize American manufacturing….
Soverli, a cybersecurity company spun out of ETH Zurich, has raised $2.6 million in pre-seed funding to introduce a new sovereign operating system layer designed to work alongside Android and iOS—without hardware changes, usability trade-offs, or ecosystem lock-in. The funding round was led by Founderful, with participation from the ETH Zurich Foundation, Venture Kick, and…
Xanadu Quantum Technologies Inc., a Canadian leader in photonic quantum computing, has been selected to participate in the newly launched Canadian Quantum Champions Program (CQCP)—a landmark federal initiative aimed at accelerating the development of fault-tolerant quantum computing and securing Canada’s long-term leadership in the sector. Through the program’s first phase, Xanadu Quantum Technologies Inc. is…
Attivare Therapeutics, Inc. has been awarded a $6.6 million grant from the Gates Foundation to accelerate development of a next-generation malaria vaccine designed for durability, affordability, and global accessibility. The funding supports advancement of the company’s proprietary ATTimmune™ bioscaffold platform, with a focus on populations in low- and middle-income countries where cold-chain logistics and repeat…
Chai Discovery, an artificial intelligence–driven biotechnology company focused on molecular design, has announced a $130 million Series B funding round, marking a major milestone in its effort to reengineer how drugs are discovered and developed. The financing values Chai Discovery at $1.3 billion and was co-led by Oak HC/FT and General Catalyst. The latest round…
Navier, a San Francisco–based deep-technology startup, has raised $5.6 million in seed funding to launch what it calls the next major leap in hardware development: Agent-Driven Engineering (ADE). The round includes backing from GV (Google Ventures), HCVC, and Y Combinator, marking a strong vote of confidence from some of Silicon Valley’s most influential investors. After…
Biotech startup Convergen has closed $10 million in Seed funding to accelerate development of its TrimTAC platform, a next-generation targeted protein degradation (TPD) technology designed to selectively clear pathogenic protein aggregates. The round was led by Qiming Venture Partners, a leading global venture capital firm specializing in healthcare and life sciences. Convergen’s proprietary TrimTAC platform…
pH7 Technologies has closed the first tranche of its USD $25.6 million Series B financing, a round expected to surpass $30 million in subsequent closings, as the Canadian cleantech firm accelerates commercialization of its next-generation critical-minerals extraction technology. The round was led by Fine Structure Ventures, with BHP Ventures joining as a strategic investor. Additional…
Paradigm Health has raised $78 million in an oversubscribed Series B round as the U.S. technology company accelerates its effort to embed clinical trials directly within routine patient care across the country and abroad. The investment was led by ARCH Venture Partners, joined by new backer DFJ Growth and returning investors including F-Prime, General Catalyst,…
IMTC, a specialized fintech provider focused on streamlining fixed income technology for the buy-side, today announced the successful closure of a $12 million Series A funding round. The financing was led by Nyca Partners, a premier venture capital firm dedicated to financial technology innovation, signaling sustained confidence in IMTC’s hyper-efficient business model. In a key…
